novo nordisk mash wegovy - Search News

Order byBest matchMost fresh

News

Novo Nordisk shares pop

· 1d · on MSN

Novo Nordisk's Weight-Loss Drug Wegovy Approved to Treat Liver Disease

Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a serious disease of the liver.Wegovy can be used for patients suffering from noncirrhotic metabolic dysfunction-associated steatohepatitis,

Continue reading

· 1d · on MSN

Novo Nordisk shares pop after Wegovy receives U.S. approval for liver disease

· 4d · on MSN

Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH

Novo Wins MASH Approval for Wegovy

The label expansion could help Novo Nordisk “help shift the momentum” for Wegovy, after a difficult start to 2025, according ...

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results